Illinois, USA, and Turkey – July 2025 — Orochem Technologies Inc., a well-recognized leader for three decades in advanced sample preparation, (U)HPLC columns, and purification technologies, is proud to announce the launch of an independent new business entity, New Vision Diagnostics LLC. This new venture, New Vision Diagnostics, drawing upon the core strengths of Orochem Technologies and Vision Biotechnology, based in Turkey, addresses the current gaps in the industry by manufacturing and offering diagnostic test kits, laboratory-developed tests (LDTs), and rapid test kits in the United States of America.
Founded in 1996 and based in Illinois, USA, Orochem Technologies has earned global recognition for its development and manufacturing of 96-well and 384-well unique sample prep plates and HPLC columns used in LC-MS analysis of vitamins, steroids, drugs of abuse, amino acids, and proteomics workflows. The company also offers OEM, Contract Manufacturing, and Private label services for its consumables. Furthermore, Orochem is a pioneer in stationary phase chemistry for solid phase extraction, HPLC columns, and has successfully established large ton-scale manufacturing plants utilizing simulated moving bed (SMB) technologies for the continuous purification of proteins, APIs…Orochem also has pilot-scale opportunities for APIs. proteins, omega-3 fatty acids, chiral APIs, oligonucleotides, and other complex molecules of the client’s choice.
Vision Biotechnology, headquartered in Turkey, specializes in PCR tests, immunochromatographic rapid test kits, sample preparation systems, and customizable diagnostic solutions. Vision adds value to the healthcare sector both locally and internationally with its R&D-driven structure. The company brings flexible manufacturing, rigorous quality standards, and a research-driven focus to the healthcare and diagnostic sectors globally.
New Vision Diagnostics, based in the United States, enables the manufacturing of molecular diagnostics and rapid test kits utilizing Orochem’s strength and infrastructure combined with Vision’s R&D excellence in molecular and rapid diagnostics. New Vision Diagnostics LLC will carry forward the diagnostic product lines previously developed by Vision, including PCR kits, rapid tests, and customizable diagnostic solutions for clinical, food safety, and veterinary applications. This strategic partnership marks a significant step forward in expanding access to high-quality, scalable, and regulatory-compliant diagnostic technologies and kits manufactured in the United States of America
